- Home
- BQ vs LIPO Comparison
BQ vs LIPO Comparison
Compare BQ & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- LIPO
- Stock Information
- Founded
- BQ 2008
- LIPO 2005
- Country
- BQ China
- LIPO United States
- Employees
- BQ N/A
- LIPO N/A
- Industry
- BQ Other Specialty Stores
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- BQ Consumer Discretionary
- LIPO Health Care
- Exchange
- BQ Nasdaq
- LIPO Nasdaq
- Market Cap
- BQ 6.0M
- LIPO 3.1M
- IPO Year
- BQ 2020
- LIPO 2022
- Fundamental
- Price
- BQ $2.09
- LIPO $2.43
- Analyst Decision
- BQ
- LIPO
- Analyst Count
- BQ 0
- LIPO 0
- Target Price
- BQ N/A
- LIPO N/A
- AVG Volume (30 Days)
- BQ 15.9K
- LIPO 160.5K
- Earning Date
- BQ 05-13-2025
- LIPO 05-20-2025
- Dividend Yield
- BQ N/A
- LIPO N/A
- EPS Growth
- BQ N/A
- LIPO N/A
- EPS
- BQ N/A
- LIPO N/A
- Revenue
- BQ $81,208,354.00
- LIPO $536,357.00
- Revenue This Year
- BQ N/A
- LIPO N/A
- Revenue Next Year
- BQ N/A
- LIPO N/A
- P/E Ratio
- BQ N/A
- LIPO N/A
- Revenue Growth
- BQ N/A
- LIPO 19.29
- 52 Week Low
- BQ $1.62
- LIPO $1.97
- 52 Week High
- BQ $7.40
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- BQ 47.09
- LIPO 46.52
- Support Level
- BQ $1.96
- LIPO $2.40
- Resistance Level
- BQ $2.25
- LIPO $2.56
- Average True Range (ATR)
- BQ 0.20
- LIPO 0.16
- MACD
- BQ 0.03
- LIPO 0.00
- Stochastic Oscillator
- BQ 44.71
- LIPO 56.15
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.